QIANHAI HEALTH(00911)
0.250-0.020-7.41%
Market data delayed 15 minutes
Login to post
- CommunityCommunity
- NewsNews
- ProfileProfile
- AnnouncementsAnnouncements
- Qianhai Health Holdings Full Year 2024 Earnings: EPS: HK$0.008 (vs HK$0.31 loss in FY 2023)
Simply Wall St. · 03-27 00:10
Qianhai Health Holdings Full Year 2024 Earnings: EPS: HK$0.008 (vs HK$0.31 loss in FY 2023) - BRIEF-Qianhai Health Holdings Says FY Net Income HKD 1.3 MillionBRIEF-Qianhai Health Holdings Says FY Net Income HKD 1.3 Million
Reuters · 03-06
- Qianhai Health Foresees Return to Profit in 2024Qianhai Health Foresees Return to Profit in 2024
MT Newswires Live · 03-06
- Qianhai Health - Expected Turnaround Due to Higher-Margin Product MiX and One-off Gain in FYQianhai Health - Expected Turnaround Due to Higher-Margin Product MiX and One-off Gain in FY
THOMSON REUTERS · 03-06
- Qianhai Health Holdings' (HKG:911) Returns On Capital Are Heading Higher
Simply Wall St. · 02-21
Qianhai Health Holdings' (HKG:911) Returns On Capital Are Heading Higher - Qianhai Health's Former Subsidiary's Dispute Hangs in Court, Disposal to Yield Gain of HK$52 MillionQianhai Health's Former Subsidiary's Dispute Hangs in Court, Disposal to Yield Gain of HK$52 Million
MT Newswires Live · 2024-12-20
- Qianhai Health Unit to Acquire Investment Holding FirmQianhai Health Unit to Acquire Investment Holding Firm
MT Newswires Live · 2024-12-09
- BRIEF-Qianhai Health Holdings Says Tang Yu Yuan Appointed As An Executive DirectorBRIEF-Qianhai Health Holdings Says Tang Yu Yuan Appointed As An Executive Director
Reuters · 2024-10-02
- Qianhai Health Holdings - Tang Yu Yuan Appointed as an Executive DirectorQianhai Health Holdings - Tang Yu Yuan Appointed as an Executive Director
THOMSON REUTERS · 2024-10-02
Company Profile
Company NameQIANHAI HEALTHMarketSEHKEstablishment Date1989Employees16Office LocationWing Tuck Commercial Centre,Room 301-3,3rd Floor,177-183 Wing Lok Street,Sheung Wan,Hong KongWebsiteZip Code- -PhoneFax852 2545 7999IntroductionQianhai Health Holdings Limited is an investment holding company principally engaged in the sourcing and wholesaling of American Ginseng. Along with subsidiaries, the Company operates its business through four segments. The Cultivated Ginseng segment is engaged in the purchasing and sale of cultivated American ginseng. The Wild Ginseng segment is engaged in the purchasing and sale of wild ginseng from the United States. The Ginseng Wine segment is engaged in the manufacturing and sale of ginseng wine. Its wine products include American wild ginseng brandy and American wild ginseng white spirit. The Others segment is engaged in the trading of other products, including dried cordyceps, dried cubilose, dried seafood and skin care products, among others.Industry
Technology DistributorsIPO Information
Listing Date2014-06-26Issue Price- -
- 1D
- 5D
- Day
- Week
- Month
High
0.250
Open
0.250
Volume%
2.82
Low
0.250
Close
0.270
T/O Rate
0.04%
抱歉，当前请求异常(-1)
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email：uservice@ttm.financial